MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 6 (2009), Issue 12 (December)

1. Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial.
   J Clin Microbiol, 47(12): 3952-7. [Abstract] [Full-text]
2. Clinical application of real-time PCR to screening critically ill and emergency-care surgical patients for methicillin-resistant Staphylococcus aureus: a quantitative analytical study.
   J Clin Microbiol, 47(12): 4102-8. [Abstract] [Full-text]
3. Molecular epidemiology and risk factors for nasal carriage of staphylococcus aureus and methicillin-resistant S. aureus in infants attending day care centers in Brazil.
   J Clin Microbiol, 47(12): 3991-7. [Abstract] [Full-text]
4. Comparison of MRSASelect Agar, CHROMagar Methicillin-Resistant Staphylococcus aureus (MRSA) Medium, and Xpert MRSA PCR for detection of MRSA in Nares: diagnostic accuracy for surveillance samples with various bacterial densities.
   J Clin Microbiol, 47(12): 3933-6. [Abstract] [Full-text]
5. Prevalence of ST9 methicillin-resistant Staphylococcus aureus among pigs and pig handlers in Malaysia.
   J Clin Microbiol, 47(12): 4138-40. [Abstract] [Full-text]
6. Population structure of Staphylococcus aureus strains isolated from intensive care unit patients in the netherlands over an 11-year period (1996 to 2006).
   J Clin Microbiol, 47(12): 4090-5. [Abstract] [Full-text]
7. Acquisition of high-level mupirocin resistance and its fitness cost among methicillin-resistant Staphylococcus aureus strains with low-level mupirocin resistance.
   J Clin Microbiol, 47(12): 4158-60. [Abstract] [Full-text]
8. MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia.
   Eur Respir J, 34(6): 1470-6. [Abstract] [Full-text]
9. Influence of Intra-articular Neutrophils on the Effects of Photodynamic Therapy for Murine MRSA Arthritis.
   Photochem Photobiol. [Abstract] [Full-text]
10. Bioactive acylphloroglucinols from Hypericum densiflorum.
    Phytother Res, 23(12): 1759-62. [Abstract] [Full-text]
11. Simultaneous intraoperative detection of methicillin-resistant Staphylococcus and pan-bacterial infection during revision surgery: use of simple DNA release by ultrasonication and real-time polymerase chain reaction.
    J Bone Joint Surg Am, 91(12): 2896-902. [Abstract] [Full-text]
12. New therapeutic choices for infections caused by methicillin-resistant Staphylococcus aureus.
    Clin Microbiol Infect, 15: 44-52. [Abstract] [Full-text]
13. Do guidelines for the prevention and control of methicillin-resistant Staphylococcus aureus make a difference?
    Clin Microbiol Infect, 15: 39-43. [Abstract] [Full-text]
14. Methicillin-resistant Staphylococcus aureus: source control and surveillance organization.
    Clin Microbiol Infect, 15: 31-8. [Abstract] [Full-text]
15. Methicillin-resistant Staphylococcus aureus in long-term-care facilities.
    Clin Microbiol Infect, 15: 26-30. [Abstract] [Full-text]
16. Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?
    Clin Microbiol Infect, 15: 17-25. [Abstract] [Full-text]
17. Methods for screening for methicillin-resistant Staphylococcus aureus carriage.
    Clin Microbiol Infect, 15: 10-6. [Abstract] [Full-text]
18. Low-level glycopeptide resistance in methicillin-resistant Staphylococcus aureus and how to test it.
    Clin Microbiol Infect, 15: 2-9. [Abstract] [Full-text]
19. MRSA as a cause of postpartum breast abscess in infant and mother.
    J Hum Lact, 25(4): 448-50. [Abstract] [Full-text]
20. Immunization protected well nourished mice but not undernourished ones from lung injury in Methicillin-resistant Staphylococcus aureus (MRSA) infection.
    BMC Microbiol, 9: 240. [Abstract] [Full-text]
21. Role of methicillin-resistant Staphylococcus aureus in head and neck infections.
    J Laryngol Otol, 123(12): 1301-7. [Abstract] [Full-text]
22. Decreased susceptibility to vancomycin in methicillin-resistant Staphylococcus aureus: a 5 year study in an Indian tertiary hospital.
    J Med Microbiol. [Abstract] [Full-text]
23. Methicillin-resistant Staphylococcus aureus sepsis after elective vaginal prolapse surgery.
    Int Urogynecol J Pelvic Floor Dysfunct, 21(1): 117-9. [Abstract] [Full-text]
24. Determination of the mutant selection window for clindamycin, doxycycline, linezolid, moxifloxacin and trimethoprim/sulfamethoxazole against community-associated meticillin-resistant Staphylococcus aureus (MRSA).
    Int J Antimicrob Agents, 35(1): 45-9. [Abstract] [Full-text]
25. Restriction fragment length polymorphism (RFLP) patterns and sequence analysis of high-level mupirocin-resistant meticillin-resistant staphylococci.
    Int J Antimicrob Agents, 35(1): 50-5. [Abstract] [Full-text]
26. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
    Int J Antimicrob Agents, 35(1): 25-9. [Abstract] [Full-text]
27. A study of the antimicrobial activity of selected synthetic and naturally occurring quinolines.
    Int J Antimicrob Agents, 35(1): 30-8. [Abstract] [Full-text]
28. Infection control practices in assisted living communities.
    Geriatr Nurs, 30(6): 417-23. [Abstract] [Full-text]
29. In vitro antimicrobial activity and mechanism of action of novel carbohydrate fatty acid derivatives against Staphylococcus aureus and MRSA.
    J Appl Microbiol. [Abstract] [Full-text]
30. Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE.
    Nanomedicine, 5(4): 452-6. [Abstract] [Full-text]
31. Physical properties and biological activity of poly(butyl acrylate-styrene) nanoparticle emulsions prepared with conventional and polymerizable surfactants.
    Nanomedicine, 5(4): 443-51. [Abstract] [Full-text]
32. Risk factors associated with methicillin resistance among Staphylococcus aureus infections in veterans.
    Infect Control Hosp Epidemiol, 31(1): 36-41. [Abstract] [Full-text]
33. Extranasal methicillin-resistant Staphylococcus aureus colonization at admission to an acute care Veterans Affairs hospital.
    Infect Control Hosp Epidemiol, 31(1): 42-6. [Abstract] [Full-text]
34. Low Rate of Methicillin-resistant Coagulase-positive Staphylococcal Colonization of Veterinary Personnel in Hong Kong.
    Zoonoses Public Health. [Abstract] [Full-text]
35. Prevention of access-related infection in dialysis.
    Expert Rev Anti Infect Ther, 7(10): 1185-200. [Abstract] [Full-text]
36. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.
    Chest, 136(6): 1554-60. [Abstract] [Full-text]
37. Augmented production of Panton-Valentine leukocidin toxin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus is associated with worse outcome in a murine skin infection model.
    J Infect Dis, 201(1): 92-6. [Abstract] [Full-text]
38. Short-term intravenous antimicrobial prophylaxis in combination with preoperative oral antibiotics on surgical site infection and methicillin-resistant Staphylococcus aureus infection in elective colon cancer surgery: results of a prospective randomized trial.
    Surg Today, 39(12): 1032-9. [Abstract] [Full-text]
39. Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search and destroy policy.
    Clin Microbiol Infect, 16(1): 78-83. [Abstract] [Full-text]
40. Molecular typing of methicillin-susceptible Staphylococcus aureus isolates collected in the Yogyakarta area in Indonesia, 2006.
    Clin Microbiol Infect, 16(1): 92-4. [Abstract] [Full-text]
41. Panton-Valentine leukocidin-positive Staphylococcus aureus skin and soft tissue infections among children in an emergency department in Madrid, Spain.
    Clin Microbiol Infect, 16(1): 74-7. [Abstract] [Full-text]
42. Biofilm dispersal of community-associated methicillin-resistant Staphylococcus aureus on orthopedic implant material.
    J Orthop Res, 28(1): 55-61. [Abstract] [Full-text]
43. Contemporary management of and outcomes from cardiac device related infections.
    Europace, 12(1): 64-70. [Abstract] [Full-text]
44. Polyclonal multiply antibiotic-resistant methicillin-resistant Staphylococcus aureus with Panton-Valentine leucocidin in England.
    J Antimicrob Chemother, 65(1): 46-50. [Abstract] [Full-text]
45. Limitations of antibiotic options for invasive infections caused by methicillin-resistant Staphylococcus aureus: is combination therapy the answer?
    J Antimicrob Chemother, 65(1): 24-36. [Abstract] [Full-text]
46. The emerging methicillin-resistant Staphylococcus aureus ST398 clone can easily be typed using the Cfr9I SmaI-neoschizomer.
    Lett Appl Microbiol, 50(1): 127-30. [Abstract] [Full-text]
47. Panton-Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus.
    Clin Microbiol Infect, 16(1): 68-73. [Abstract] [Full-text]
48. Panton-Valentine Leucocidin-related disease in England and Wales.
    Clin Microbiol Infect, 16(1): 86-8. [Abstract] [Full-text]
49. Staphylococcus aureus Panton-Valentine leukocidin targets muscle tissues in a child with myositis and necrotizing fasciitis.
    Clin Infect Dis, 50(1): 69-72. [Abstract] [Full-text]
50. Linezolid-resistant methicillin-resistant Staphylococcus aureus isolated after long-term, repeated use of linezolid.
    J Infect Chemother, 15(6): 417-9. [Abstract] [Full-text]
51. Antimicrobial susceptibility of pathogens isolated from more than 10,000 patients with infectious respiratory diseases: a 25-year longitudinal study.
    J Infect Chemother, 15(6): 347-60. [Abstract] [Full-text]
52. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.
    Arch Ophthalmol, 127(12): 1581-3. [Abstract] [Full-text]
53. Antimicrobial Properties of Light-activated Polyurethane Containing Indocyanine Green.
    J Biomater Appl. [Abstract] [Full-text]
54. Incidence of invasive community-onset Staphylococcus aureus infections in children in Central New York.
    J Pediatr, 156(1): 152-154.e1. [Abstract] [Full-text]
55. OUTPATIENT PARENTERAL ANTIMICROBIAL THERAPY -TREATED BONE AND JOINT INFECTIONS IN A TROPICAL SETTING.
    Intern Med J. [Abstract] [Full-text]
56. Prevalence of Staphylococcus aureus and Methicillin-Resistant Staphylococcus aureus Carriage in Three Populations.
    J Vet Intern Med. [Abstract] [Full-text]
57. Methicillin-resistant Staphylococcus aureus in food products: cause for concern or case for complacency?
    Clin Microbiol Infect, 16(1): 11-5. [Abstract] [Full-text]
58. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study.
    PLoS One, 4(12): e8305. [Abstract] [Full-text]
59. Structure and mechanism of the lincosamide antibiotic adenylyltransferase LinB.
    Structure, 17(12): 1649-59. [Abstract] [Full-text]
60. Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infections.
    Expert Rev Anti Infect Ther, 8(1): 95-106. [Abstract] [Full-text]
61. A simplified three-times weekly daptomycin dosing regimen for chronic hemodialysis patients.
    Expert Rev Anti Infect Ther, 8(1): 11-4. [Abstract] [Full-text]
62. Changing incidence of methicillin-resistant staphylococcus aureus skin abscesses in a pediatric emergency department.
    Pediatr Emerg Care, 25(12): 831-4. [Abstract] [Full-text]
63. Three cases of correctional litigation: learning from the root causes.
    J Correct Health Care, 16(1): 39-47. [Abstract] [Full-text]
64. In vitro and in vivo efficacies of teicoplanin-loaded calcium sulfate for treatment of chronic methicillin-resistant Staphylococcus aureus osteomyelitis.
    Antimicrob Agents Chemother, 54(1): 170-6. [Abstract] [Full-text]
65. Multiple-dose safety, tolerability, and pharmacokinetics of oral nemonoxacin (TG-873870) in healthy volunteers.
    Antimicrob Agents Chemother, 54(1): 411-7. [Abstract] [Full-text]
66. Dose escalation study of the safety, tolerability, and pharmacokinetics of nemonoxacin (TG-873870), a novel potent broad-spectrum nonfluorinated quinolone, in healthy volunteers.
    Antimicrob Agents Chemother, 54(1): 405-10. [Abstract] [Full-text]
67. In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa.
    Antimicrob Agents Chemother, 54(1): 116-25. [Abstract] [Full-text]
68. Influence of tigecycline on expression of virulence factors in biofilm-associated cells of methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 54(1): 380-7. [Abstract] [Full-text]
69. Prevention and treatment of Staphylococcus aureus pneumonia with a beta-cyclodextrin derivative.
    Antimicrob Agents Chemother, 54(1): 298-304. [Abstract] [Full-text]
70. In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods.
    Antimicrob Agents Chemother, 54(1): 157-63. [Abstract] [Full-text]
71. Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections.
    Expert Opin Drug Saf, 9(1): 9-14. [Abstract] [Full-text]
72. The use of a critical care consult team to identify risk for methicillin-resistant Staphylococcus aureus infection and the potential for early intervention: a pilot study.
    Crit Care Med, 38(1): 109-13. [Abstract] [Full-text]
73. Is there an association between nosocomial infection rates and bacterial cross transmissions?
    Crit Care Med, 38(1): 46-50. [Abstract] [Full-text]
74. Short communication: methicillin-resistant Staphylococcus aureus infections in children and young adults infected with HIV.
    AIDS Res Hum Retroviruses, 25(12): 1219-24. [Abstract] [Full-text]
75. A histidine-to-arginine substitution in Panton-Valentine leukocidin from USA300 community-acquired methicillin-resistant Staphylococcus aureus does not impair its leukotoxicity.
    Infect Immun, 78(1): 260-4. [Abstract] [Full-text]
76. Results of nasal screening for methicillin-resistant Staphylococcus aureus during a neonatal intensive care unit outbreak.
    Am J Perinatol, 27(1): 79-81. [Abstract] [Full-text]
77. Ceanothane and lupane type triterpenes from Zizyphus joazeiro - an anti-staphylococcal evaluation.
    Planta Med, 76(1): 47-52. [Abstract] [Full-text]
78. Pediatric subperiosteal orbital abscess secondary to acute sinusitis: a 5-year review.
    Am J Otolaryngol. [Abstract] [Full-text]
79. A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.
    Pharmacotherapy, 30(1): 80-94. [Abstract] [Full-text]
80. Methicillin-resistant Staphylococcus aureus in middle ear fluid of children.
    Clin Pediatr (Phila), 49(1): 66-8. [Abstract] [Full-text]
81. SaeR binds a consensus sequence within virulence gene promoters to advance USA300 pathogenesis.
    J Infect Dis, 201(2): 241-54. [Abstract] [Full-text]
82. Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes.
    J Infect Dis, 201(2): 233-40. [Abstract] [Full-text]
83. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit.
    Clin Infect Dis, 50(2): 210-7. [Abstract] [Full-text]
84. Looking toward basic science for potential drug discovery targets against community-associated MRSA.
    Med Res Rev, 30(1): 1-22. [Abstract] [Full-text]
85. New antimicrobial hexapeptides: synthesis, antimicrobial activities, cytotoxicity, and mechanistic studies.
    ChemMedChem, 5(1): 86-95. [Abstract] [Full-text]
86. Methicillin-resistant Staphylococcus aureus (MRSA)-active metabolites from Platanus occidentalis (American Sycamore).
    J Nat Prod, 72(12): 2141-4. [Abstract] [Full-text]
87. Bactericidal effect of photodynamic therapy using Na-pheophorbide a: evaluation of adequate light source.
    Photomed Laser Surg, 27(6): 849-53. [Abstract] [Full-text]
88. Do changes in antimicrobial resistance necessitate reconsideration of surgical antimicrobial prophylaxis strategies?
    Surg Infect (Larchmt), 10(6): 557-62. [Abstract] [Full-text]
89. Mechanisms of bacterial virulence in pulmonary infections.
    Curr Opin Crit Care, 16(1): 8-12. [Abstract] [Full-text]
90. Green tea extract weakens the antibacterial effect of amoxicillin in methicillin-resistant Staphylococcus aureus infected mice.
    Phytother Res, 24(1): 141-5. [Abstract] [Full-text]
91. The Search and Destroy Strategy Prevents Spread and Long-term Carriage of MRSA; Results from Follow-up Screening of a Large ST22 (E-MRSA 15) Outbreak in Denmark.
    Clin Microbiol Infect. [Abstract] [Full-text]
92. Secular Trends and Dynamics of Hospital Associated Methicillin-Resistant Staphylococcus aureus.
    Clin Microbiol Infect. [Abstract] [Full-text]
93. Panton Valentine Leukocidin associated Staphylococcal Disease: A Cross Sectional Study at a London Hospital, England.
    Clin Microbiol Infect. [Abstract] [Full-text]
94. A selective broth enrichment combined with real-time nuc-mecA-PCR in the exclusion of MRSA.
    APMIS, 118(1): 74-80. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.